Home › Cancro ovarico › Montana › Billings
Studi clinici su Cancro ovarico a Billings, MT
9 studi su Cancro ovarico cercano partecipanti presso sedi a Billings e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
In reclutamentoFase 2
- Billings Clinic Cancer Center, Billings
Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer
In reclutamentoFase 3
- Research Site, Billings
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
In reclutamentoFase 2
- Intermountain Health - Intermountain Health West End Clinic /ID# 278470, Billings
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
In reclutamentoFase 3
- Billings Clinic, Billings
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
In reclutamentoFase 2
- St. Vincent Regional Hospital - West End Clinic, Billings
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
In reclutamento
- Billings Clinic Cancer Center, Billings
- Saint Vincent Healthcare, Billings
- Saint Vincent Frontier Cancer Center, Billings
- e altri 1
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
In reclutamentoFase 3
- Billings Clinic Cancer Center, Billings
- Saint Vincent Healthcare, Billings
- Saint Vincent Frontier Cancer Center, Billings
- e altri 1
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
In reclutamentoFase 3
- St. Vincent Gynecologic Oncology, Billings
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Billings
Studi su Cancro ovarico in altre città
- Houston, TX89 studi
- New York City, NY69 studi
- Boston, MA61 studi
- Los Angeles, CA50 studi
- Nashville, TN49 studi
- Arlington, VA46 studi
- Philadelphia, PA44 studi
- Columbus, OH39 studi
- St. Louis, MO38 studi
- Chicago, IL36 studi
- San Antonio, TX31 studi
- Cleveland, OH30 studi
Altri studi a Billings
- Cancro del polmone non a piccole cellule17 studi
- Cancro alla prostata15 studi
- Cancro ai polmoni13 studi
- Cancro al seno10 studi
- Melanoma7 studi
- Leucemia linfatica cronica7 studi
- Leucemia mieloide acuta7 studi
- Cancro della vescica6 studi
- Cancro del colon6 studi
- Cancro colorettale6 studi
- Cancro del retto5 studi
- Carcinoma a cellule squamose della testa e del collo4 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.